FlowOx 2.0, developed in co-creation between Norwegian company Otivio AS and Innokas Medical, is a clinically promising, patented and cost-efficient home treatment solution for Peripheral Arterial...
Recent Posts
It has been noted that the occurrence of use errors, also called as human error, increases the number and severity of incidents related to the use of medical devices. Use errors typically occur...
Across industries, the pace to introduce new products is increasing. This puts pressure on companies to shorten the design and development cycles. Medical devices are no exception in this respect.
With their next-generation innovation, Synoste aims to renew surgical treatment related to bone deformities. Innokas Medical is involved in this mission by being one of Synoste's co-creation...
Healthcare technology is one of the largest high-tech export segments of Finnish industry, and it continues to grow strongly year after year. In addition to growth, the industry is evolving with...
WellO2, innovation developed by the Finnish company WellO2 Oy (formerly known as Hapella Oy), is a breathing exercise device that strengthens and cleanses the lungs. The mission of the company is...
The collaborative consortium has received a significant funding from Business Finland. This two-year Stroke-DATA -project, which is one part of Business Finland’s Smart Life program, is carried...
Norwegian healthtech innovator Augere Medical AS has selected Innokas Medical as their co-creation partner to offer quality and regulatory as well as design and development support to bring their...
When creating a new medical device to the market, there’s much more that goes into designing, developing and introducing it to the market. To be able to enter the certain markets, the development...
